Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.

Yamamori H, Hashimoto R, Ishima T, Kishi F, Yasuda Y, Ohi K, Fujimoto M, Umeda-Yano S, Ito A, Hashimoto K, Takeda M.

Neurosci Lett. 2013 Nov 27;556:37-41. doi: 10.1016/j.neulet.2013.09.059. Epub 2013 Oct 18.

PMID:
24141084
[PubMed - indexed for MEDLINE]
Free Article
2.

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.

Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M, Hashimoto K.

PLoS One. 2012;7(8):e42676. doi: 10.1371/journal.pone.0042676. Epub 2012 Aug 3. Erratum in: PLoS One. 2013;8(2). doi:10.1371/annotation/85a3fa48-980b-4f95-bb43-b33b1c3e0ac6.

PMID:
22880079
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.

Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, Nakazato M, Shimizu E, Hashimoto K, Iyo M.

Psychiatry Res. 2014 Feb 28;215(2):268-73. doi: 10.1016/j.psychres.2013.12.009. Epub 2013 Dec 14.

PMID:
24377440
[PubMed - in process]
4.

Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.

Pirildar S, Gönül AS, Taneli F, Akdeniz F.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):709-13.

PMID:
15276697
[PubMed - indexed for MEDLINE]
5.

Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.

Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen da C, Kosten TR, Zhang XY.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1508-12. doi: 10.1016/j.pnpbp.2009.08.011. Epub 2009 Aug 29.

PMID:
19720106
[PubMed - indexed for MEDLINE]
6.

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.

Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR.

J Psychiatr Res. 2007 Jan-Feb;41(1-2):31-5. Epub 2006 Mar 20.

PMID:
16546213
[PubMed - indexed for MEDLINE]
7.

Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.

Lee BH, Kim YK.

Neuropsychobiology. 2009;59(1):51-8. doi: 10.1159/000205518. Epub 2009 Mar 6.

PMID:
19270464
[PubMed - indexed for MEDLINE]
8.

Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.

Pedrini M, Chendo I, Grande I, Lobato MI, Belmonte-de-Abreu PS, Lersch C, Walz J, Kauer-Sant'anna M, Kapczinski F, Gama CS.

Neurosci Lett. 2011 Mar 24;491(3):207-10. doi: 10.1016/j.neulet.2011.01.039. Epub 2011 Jan 21.

PMID:
21256922
[PubMed - indexed for MEDLINE]
Free Article
9.

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.

Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ.

Mol Psychiatry. 2011 Sep;16(9):960-72. doi: 10.1038/mp.2010.88. Epub 2010 Aug 24. Review.

PMID:
20733577
[PubMed - indexed for MEDLINE]
10.

Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.

Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, Shinoda N, Nakazato M, Kumakiri C, Okada S, Iyo M.

Neurosci Lett. 2003 Nov 13;351(2):111-4.

PMID:
14583394
[PubMed - indexed for MEDLINE]
11.

Effects of antipsychotics on the serum BDNF levels in schizophrenia.

Chen CC, Huang TL.

Psychiatry Res. 2011 Oct 30;189(3):327-30. doi: 10.1016/j.psychres.2011.01.011. Epub 2011 Feb 12.

PMID:
21320726
[PubMed - indexed for MEDLINE]
12.

Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.

Tan YL, Zhou DF, Zhang XY.

Schizophr Res. 2005 May 1;74(2-3):263-70.

PMID:
15722005
[PubMed - indexed for MEDLINE]
13.

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY.

Neurosci Lett. 2005 Jul 1-8;382(1-2):27-32. Epub 2005 Mar 19.

PMID:
15911116
[PubMed - indexed for MEDLINE]
14.

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.

Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Katsuki A, Hayashi K, Atake K, Tomita M, Nakamura J.

Hum Psychopharmacol. 2012 Jan;27(1):33-8. doi: 10.1002/hup.1257. Epub 2011 Dec 30.

PMID:
22213405
[PubMed - indexed for MEDLINE]
15.

Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.

Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR.

J Psychiatr Res. 2007 Dec;41(12):997-1004. Epub 2006 Nov 13.

PMID:
17095017
[PubMed - indexed for MEDLINE]
16.

Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts.

Södersten K, Pålsson E, Ishima T, Funa K, Landén M, Hashimoto K, Ågren H.

J Affect Disord. 2014 May;160:1-9. doi: 10.1016/j.jad.2014.01.009. Epub 2014 Feb 24.

PMID:
24709015
[PubMed - in process]
17.

Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.

Martinotti G, Di Iorio G, Marini S, Ricci V, De Berardis D, Di Giannantonio M.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):347-56. Review.

PMID:
23034254
[PubMed - indexed for MEDLINE]
18.

Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.

Ajami A, Hosseini SH, Taghipour M, Khalilian A.

Scand J Immunol. 2014 Jul;80(1):36-42. doi: 10.1111/sji.12158.

PMID:
24498860
[PubMed - indexed for MEDLINE]
19.

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.

Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, Nakano Y, Shinkai K, Mitoma M, Ohta M, Shinkai T, Nakamura J.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1072-7. Epub 2007 Mar 24.

PMID:
17459549
[PubMed - indexed for MEDLINE]
20.

Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.

Chen da C, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, Li YL, Wang N, Yang KB, Xiu MH, Kosten TR, Zhang XY.

Psychopharmacology (Berl). 2009 Dec;207(3):375-80. doi: 10.1007/s00213-009-1665-6. Epub 2009 Sep 29.

PMID:
19787338
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk